Compile Data Set for Download or QSAR
Report error Found 164 Enz. Inhib. hit(s) with all data for entry = 11608
TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633037(US20230348456, Compound 58)
Affinity DataIC50: 1nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633007(US20230348456, Compound 27)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633029(US20230348456, Compound 50)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633033(US20230348456, Compound 54)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633036(US20230348456, Compound 57)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633040(US20230348456, Compound 61)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633083(US20230348456, Compound 104)
Affinity DataIC50: 2nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM632990(US20230348456, Compound 10)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM632999(US20230348456, Compound 19)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633002(US20230348456, Compound 22)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633009(US20230348456, Compound 29)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633039(US20230348456, Compound 60)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633043(US20230348456, Compound 64)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633045(US20230348456, Compound 66)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633046(US20230348456, Compound 67)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633051(US20230348456, Compound 72)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633058(US20230348456, Compound 79)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633086(US20230348456, Compound 107)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633114(US20230348456, Compound 135)
Affinity DataIC50: 3nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM632966(US20230348456, Compound 1)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM632987(US20230348456, Compound 7)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633003(US20230348456, Compound 23)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633008(US20230348456, Compound 28)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633032(US20230348456, Compound 53)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633034(US20230348456, Compound 55)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633044(US20230348456, Compound 65)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633049(US20230348456, Compound 70)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633052(US20230348456, Compound 73)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633056(US20230348456, Compound 77)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633060(US20230348456, Compound 81)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633090(US20230348456, Compound 111)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633111(US20230348456, Compound 132)
Affinity DataIC50: 4nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM632984(US20230348456, Compound 4)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM632991(US20230348456, Compound 11)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633006(US20230348456, Compound 26)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633031(US20230348456, Compound 52)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633038(US20230348456, Compound 59)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633062(US20230348456, Compound 83)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633067(US20230348456, Compound 88)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633070(US20230348456, Compound 91)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633077(US20230348456, Compound 98)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633079(US20230348456, Compound 100)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633107(US20230348456, Compound 128)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633113(US20230348456, Compound 134)
Affinity DataIC50: 5nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM632994(US20230348456, Compound 14)
Affinity DataIC50: 6nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633001(US20230348456, Compound 21)
Affinity DataIC50: 6nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633011(US20230348456, Compound 32)
Affinity DataIC50: 6nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633047(US20230348456, Compound 68)
Affinity DataIC50: 6nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633054(US20230348456, Compound 75)
Affinity DataIC50: 6nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetMyelin transcription factor 1(Human)
Repare Therapeutics

US Patent
LigandPNGBDBM633059(US20230348456, Compound 80)
Affinity DataIC50: 6nMAssay Description:Detection of Myt1 kinase activity utilized a recombinant human Myt1 kinase assay measuring the hydrolysis of ATP using a commercially available ADP-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 164 total ) | Next | Last >>
Jump to: